Defendant Name:
Harry Craig Dees
Defendant Type:
Individual
Initial Case Details
Legal Case Name
SEC v. Harry Craig Dees
First Document Date
12-Dec-2017
Initial Filing Format
Civil Proceeding
Case Number
17-cv-00532
Allegation Type
Issuer Reporting and Disclosure
Federal District Court
Tennessee, Eastern District of Tennessee
Affiliations
- Former: Director—Chairman at Provectus Biopharmaceuticals, Inc. (2002—February 27, 2016)
- Former: CEO at Provectus Biopharmaceuticals, Inc. (2002—February 27, 2016)
Violations Alleged
•
Rules 13b2-1, 13b2-2 Exchange Act
Related Violations Alleged
Harry Craig Dees is alleged to have aided and abetted Provectus Biopharmaceuticals, Inc.'s violation of Rule 12b-20 of the Exchange Act.
Harry Craig Dees is alleged to have aided and abetted an unidentified individual or entity's violation of Rule 12b-20 of the Exchange Act.
Harry Craig Dees is alleged to have aided and abetted Provectus Biopharmaceuticals, Inc.'s violation of Sec 13(a) of the Exchange Act.
Harry Craig Dees is alleged to have aided and abetted an unidentified individual or entity's violation of Sec 13(a) of the Exchange Act.
Harry Craig Dees is alleged to have aided and abetted Provectus Biopharmaceuticals, Inc.'s violation of Rule 13a-1 of the Exchange Act.
Harry Craig Dees is alleged to have aided and abetted an unidentified individual or entity's violation of Rule 13a-1 of the Exchange Act.
Harry Craig Dees is alleged to have aided and abetted Provectus Biopharmaceuticals, Inc.'s violation of Sec 13(b)(2)(A) of the Exchange Act.
Harry Craig Dees is alleged to have aided and abetted an unidentified individual or entity's violation of Sec 13(b)(2)(A) of the Exchange Act.
Harry Craig Dees is alleged to have aided and abetted Provectus Biopharmaceuticals, Inc.'s violation of Sec 14(a) of the Exchange Act.
Harry Craig Dees is alleged to have aided and abetted Provectus Biopharmaceuticals, Inc.'s violation of Rule 14a-3 of the Exchange Act.
Harry Craig Dees is alleged to have aided and abetted Provectus Biopharmaceuticals, Inc.'s violation of Rule 14a-9 of the Exchange Act.
Resolutions
Bars:
- Bar from acting as Director or Officer of a public company (of unspecified duration)
First Resolution Date
28-May-2019
Headline Total Penalty and Disgorgement
$5,261,769
